Should You Buy Envista Holdings Corp (NVST) Today? Analysis, Price Targets, and 2026 Outlook.
Analysis Updated At
2026/01/26
Envista Holdings Corp (NVST) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the stock has shown some positive technical indicators and analysts have recently upgraded price targets, the company's financial performance is concerning, with significant drops in net income and EPS. Additionally, there are no strong proprietary trading signals or recent news catalysts to justify an immediate buy decision. Holding off for now is the most prudent choice.
Technical Analysis
The technical indicators show mixed signals. The MACD is positive but contracting, the RSI is neutral at 46.919, and the moving averages are bullish (SMA_5 > SMA_20 > SMA_200). However, the stock is trading near its support level (S1: 23.07), with resistance at R1: 25.122. The overall trend does not strongly indicate a buy signal.
Analyst Ratings and Price Target Trends
Analysts have shown a slightly positive trend. Mizuho upgraded the stock to Neutral from Underperform with a price target of $24, citing greater earnings visibility. Barclays initiated coverage with an Overweight rating and a $24 price target. Stifel maintained a Buy rating, noting an improvement in the dental market. However, JPMorgan and Mizuho remain Neutral on the stock, reflecting mixed sentiment.
Wall Street analysts forecast NVST stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for NVST is 22.22 USD with a low forecast of 18 USD and a high forecast of 27 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Wall Street analysts forecast NVST stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for NVST is 22.22 USD with a low forecast of 18 USD and a high forecast of 27 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Current: 24.080
Current: 24.080
